Sen­so­ri­on part­ners on in­jec­tion sys­tem for ther­a­py de­liv­ery; Kymera and X-Chem ex­pand deal

The French biotech Sen­so­ri­on has brought on a part­ner to help in the de­vel­op­ment of an in­jec­tion sys­tem for its gene ther­a­py prod­ucts.

On Tues­day, the biotech an­nounced that EVEON, a de­sign­er and man­u­fac­tur­er of med­ical de­vices for drug de­liv­ery, will work with Sen­so­ri­on to de­sign and even­tu­al­ly de­vel­op an in­jec­tion sys­tem for its gene ther­a­py prod­ucts for the in­ner ear. Sen­so­ri­on is cur­rent­ly de­vel­op­ing two gene ther­a­py can­di­dates meant to treat deaf­ness caused by ge­net­ic mu­ta­tions in adults and chil­dren.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER